Roger A'Hern


Ontology type: schema:Person     


Person Info

NAME

Roger

SURNAME

A'Hern

Publications in SciGraph latest 50 shown

  • 2015-12 A phase II trial to assess the activity of gemcitabine and docetaxel as first line chemotherapy treatment in patients with unresectable leiomyosarcoma in CLINICAL SARCOMA RESEARCH
  • 2014-05 DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy in RADIATION AND ENVIRONMENTAL BIOPHYSICS
  • 2014-04 Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-06 Taxane benefit in breast cancer—a role for grade and chromosomal stability in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2013-04 Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2013-02 Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-10 Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo in BREAST CANCER RESEARCH
  • 2012-09 Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin in BRITISH JOURNAL OF CANCER
  • 2012-06 Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2012-05 Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer in BRITISH JOURNAL OF CANCER
  • 2012-04 ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer in BREAST CANCER RESEARCH
  • 2011-12 Phase II investigation of a PARP inhibitor (olaparib) in castration resistant prostate cancer (CRPC) which incorporates the possibility that treatment effect may be restricted to biomarker defined subgroups in TRIALS
  • 2011-10 Multicentric breast cancer: clonality and prognostic studies in BREAST CANCER RESEARCH AND TREATMENT
  • 2010-10 Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer in BREAST CANCER RESEARCH
  • 2010-10 Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2010-07 Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study in BRITISH JOURNAL OF CANCER
  • 2010-01 Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2009-12 Who would have thought a single Ki67 measurement would predict long-term outcome? in BREAST CANCER RESEARCH
  • 2009-10 Correlation of age and hormone replacement therapy with breast density as assessed by Quantra™ in BREAST CANCER RESEARCH
  • 2009-07 The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2009-03 Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines in FAMILIAL CANCER
  • 2007-12 Short-term presurgical treatment for all? in BREAST CANCER RESEARCH
  • 2006-03 Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer in BRITISH JOURNAL OF CANCER
  • 2005-12 Experience in the use of the palliative care outcome scale in SUPPORTIVE CARE IN CANCER
  • 2005-09 An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer in SUPPORTIVE CARE IN CANCER
  • 2004-11 Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma in BRITISH JOURNAL OF CANCER
  • 2004-08 A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer in BRITISH JOURNAL OF CANCER
  • 2004-08 A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma in BRITISH JOURNAL OF CANCER
  • 2004-07 Prognosis of Lymph Node Metastasis in Soft Tissue Sarcoma in ANNALS OF SURGICAL ONCOLOGY
  • 2004-03 A Quality-of-Life Study in High-Risk (Thickness≥2 mm) Cutaneous Melanoma Patients in a Randomized Trial of 1-cm versus 3-cm Surgical Excision Margins in JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS
  • 2004 CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. in HAEMATOLOGICA
  • 2004 Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia. in HAEMATOLOGICA
  • 2003-11 Studies of the Potential Utility of Ki67 as a Predictive Molecular Marker of Clinical Response in Primary Breast Cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2003-09 Buttock Soft Tissue Sarcoma: Clinical Features, Treatment, and Prognosis in ANNALS OF SURGICAL ONCOLOGY
  • 2002-04 Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia? in BRITISH JOURNAL OF CANCER
  • 2002 Prostate-Specific Antigen in Nipple Aspiration Fluid: Menstrual Cycle Variability and Correlation with Serum Prostate-Specific Antigen in TUMOR BIOLOGY
  • 2001-11 No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours in BRITISH JOURNAL OF CANCER
  • 2001-05 Prognostic Index for Extremity Soft Tissue Sarcomas With Isolated Local Recurrence in ANNALS OF SURGICAL ONCOLOGY
  • 2001-03 Leukopenia predicts outcome in haemato-oncological patients requiring intensive care in CRITICAL CARE
  • 2000-02 Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene in BRITISH JOURNAL OF CANCER
  • 1999-04 The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer in BRITISH JOURNAL OF CANCER
  • 1999-04 The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer in BRITISH JOURNAL OF CANCER
  • 1999-03 Fatigue in advanced cancer: a prospective controlled cross-sectional study in BRITISH JOURNAL OF CANCER
  • 1999-02 The role of genetic factors in predisposition to squamous cell cancer of the head and neck in BRITISH JOURNAL OF CANCER
  • 1999-01 Modified Staging System for Extremity Soft Tissue Sarcomas in ANNALS OF SURGICAL ONCOLOGY
  • 1998-12 Chemotherapy for ovarian cancer - a consensus statement on standard practice in BRITISH JOURNAL OF CANCER
  • 1998-04 Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-α) and interleukin (IL-2) in patients with metastatic melanoma in BRITISH JOURNAL OF CANCER
  • 1998-03 Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy in BREAST CANCER RESEARCH AND TREATMENT
  • 1997-03 The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance in BRITISH JOURNAL OF CANCER
  • 1996-10 A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.18886.3f", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412947.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.46699.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5477.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411326.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.464688.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.477842.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10025.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417079.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.443984.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5072.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10698.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412920.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416353.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.430814.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.11485.39", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.424926.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.451052.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4367.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4305.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.13097.3c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417815.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417068.c", 
            "type": "Organization"
          }
        ], 
        "familyName": "A'Hern", 
        "givenName": "Roger", 
        "id": "sg:person.01313073773.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313073773.41"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:09", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_839.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01313073773.41'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01313073773.41'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01313073773.41'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01313073773.41'


     

    This table displays all metadata directly associated to this object as RDF triples.

    60 TRIPLES      10 PREDICATES      33 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01313073773.41 schema:affiliation Nb8ce0cd14b7042da8a9f8ce80766f18d
    2 https://www.grid.ac/institutes/grid.10025.36
    3 https://www.grid.ac/institutes/grid.10698.36
    4 https://www.grid.ac/institutes/grid.11485.39
    5 https://www.grid.ac/institutes/grid.13097.3c
    6 https://www.grid.ac/institutes/grid.411326.3
    7 https://www.grid.ac/institutes/grid.412920.c
    8 https://www.grid.ac/institutes/grid.412947.d
    9 https://www.grid.ac/institutes/grid.416353.6
    10 https://www.grid.ac/institutes/grid.417068.c
    11 https://www.grid.ac/institutes/grid.417079.c
    12 https://www.grid.ac/institutes/grid.417815.e
    13 https://www.grid.ac/institutes/grid.424926.f
    14 https://www.grid.ac/institutes/grid.4305.2
    15 https://www.grid.ac/institutes/grid.430814.a
    16 https://www.grid.ac/institutes/grid.4367.6
    17 https://www.grid.ac/institutes/grid.443984.6
    18 https://www.grid.ac/institutes/grid.451052.7
    19 https://www.grid.ac/institutes/grid.464688.0
    20 https://www.grid.ac/institutes/grid.46699.34
    21 https://www.grid.ac/institutes/grid.477842.a
    22 https://www.grid.ac/institutes/grid.5072.0
    23 https://www.grid.ac/institutes/grid.5477.1
    24 schema:familyName A'Hern
    25 schema:givenName Roger
    26 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313073773.41
    27 schema:sdDatePublished 2019-03-07T15:09
    28 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    29 schema:sdPublisher Nca81f10ca16c44a888bc24bee3bad775
    30 sgo:license sg:explorer/license/
    31 sgo:sdDataset persons
    32 rdf:type schema:Person
    33 Nb8ce0cd14b7042da8a9f8ce80766f18d schema:affiliation https://www.grid.ac/institutes/grid.18886.3f
    34 sgo:isCurrent true
    35 rdf:type schema:OrganizationRole
    36 Nca81f10ca16c44a888bc24bee3bad775 schema:name Springer Nature - SN SciGraph project
    37 rdf:type schema:Organization
    38 https://www.grid.ac/institutes/grid.10025.36 schema:Organization
    39 https://www.grid.ac/institutes/grid.10698.36 schema:Organization
    40 https://www.grid.ac/institutes/grid.11485.39 schema:Organization
    41 https://www.grid.ac/institutes/grid.13097.3c schema:Organization
    42 https://www.grid.ac/institutes/grid.18886.3f schema:Organization
    43 https://www.grid.ac/institutes/grid.411326.3 schema:Organization
    44 https://www.grid.ac/institutes/grid.412920.c schema:Organization
    45 https://www.grid.ac/institutes/grid.412947.d schema:Organization
    46 https://www.grid.ac/institutes/grid.416353.6 schema:Organization
    47 https://www.grid.ac/institutes/grid.417068.c schema:Organization
    48 https://www.grid.ac/institutes/grid.417079.c schema:Organization
    49 https://www.grid.ac/institutes/grid.417815.e schema:Organization
    50 https://www.grid.ac/institutes/grid.424926.f schema:Organization
    51 https://www.grid.ac/institutes/grid.4305.2 schema:Organization
    52 https://www.grid.ac/institutes/grid.430814.a schema:Organization
    53 https://www.grid.ac/institutes/grid.4367.6 schema:Organization
    54 https://www.grid.ac/institutes/grid.443984.6 schema:Organization
    55 https://www.grid.ac/institutes/grid.451052.7 schema:Organization
    56 https://www.grid.ac/institutes/grid.464688.0 schema:Organization
    57 https://www.grid.ac/institutes/grid.46699.34 schema:Organization
    58 https://www.grid.ac/institutes/grid.477842.a schema:Organization
    59 https://www.grid.ac/institutes/grid.5072.0 schema:Organization
    60 https://www.grid.ac/institutes/grid.5477.1 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...